Introduction {#Sec1}
============

Inflammatory sinus disease is the most common pathological condition involving the paranasal sinuses, and the chronic inflammatory disease of undefined etiopathogenesis of the upper airways is considered to affect 6 to 13 % of the population \[[@CR1], [@CR2]\].

All forms of maxillary sinusitis (more specific chronic sinusitis) were related with loss of an anatomic barrier and with innate immune response. The latter normally prevents infection of healthy sinuses, however, in some patients, this prevention is ineffective and they may be considered highly predisposed to trigger repeated clinical conditions of acute sinusitis. Added to this, maxillary sinusitis was associated with the loss of sterility (observed in healthy sinuses) and was routinely linked with the presence of gram-negative aerobic bacteria---*Staphylococcus aureus*---and other anaerobic bacteria \[[@CR3], [@CR4]\]. In fact, the classic odontogenic infection of the maxillary sinus is composed of a mixed aerobic-anaerobic infection, with anaerobes predominating \[[@CR2]\]. Therefore, several authors support the theory that oral bacteria may ascend from the mouth to the maxillary sinus and consequently be the cause of sinus infections \[[@CR1], [@CR2], [@CR4]--[@CR8]\]. This type of maxillary sinusitis---odontogenic---occurs when the Schneider membrane is violated. Also, since the very beginning of investigation about the etiology of the maxillary sinusitis, dental factors have been associated to 10--12 % cases of chronic maxillary sinusitis \[[@CR7]\].

The oral conditions that were related with the odontogenic infection of the sinus include infections of the maxillary posterior teeth (periapical granulomas caused by caries, periodontal disease, cysts roots or incorrect endodontics procedures), oroantral fistula, pathologic lesions of the jaws and teeth, maxillary dental trauma or iatrogenic causes, such as sinus foreign bodies (dental fillings, teeth roots, broken instruments or even dental implants) \[[@CR1], [@CR6], [@CR9]\].

The role played by host inflammatory response in the maxillary sinus disease has been called into question for investigation for more than a decade. Although, it is believed that this response may be controlled by specific genes, which determine a more or less pronounced phenotypic scene disease \[[@CR2], [@CR3], [@CR10]--[@CR12]\].

In fact, specific gene polymorphisms \[base-pair substitutions in the DNA sequence, frequently called single nucleotide polymorphisms (SNPs)\] have been proved to interfere with the innate pathway of immune recognition and with the regulation of the host response. The latter relation has been also suggested for the maxillary sinusitis and rhinitis pathway \[[@CR2], [@CR3], [@CR12]--[@CR14]\].

Some studies have reported a relation between specific genetic variations in the interleukin-1 receptor-associated kinase-4 (*IRAK4*) gene, the host susceptibility to develop rhinitis and the prevalence of Gram-positive bacterial infections in critically ill adults \[[@CR13], [@CR14]\]. Other investigations have also added the existence of a relationship between Gram-positive recurrent infections and deficient defence reactions in paediatric patients with genetic *IRAK4* mutations \[[@CR15]--[@CR17]\].

IRAK4 is a serine-threonine kinase that is considered a key player in the signalling of the MyD88-depending pathway of the Toll-like/IL-1-receptor (TIR) and also in other Toll-like receptor (TLR) signalling, except TLR3 \[[@CR18]\]. When the *IRAK4* gene interacts with *MyD88*, it leads to the activation of the nuclear factor-κb (NF-κB) and, consequently, to the transcription of inflammatory mediators (such as IL-6) \[[@CR18]\].

Zhang et al. (2011) reported a gender- and allergen-dependent association pattern between some *IRAK4* gene polymorphisms and allergic rhinitis in a Chinese population.

Moreover, the Sutherland and co-workers study (2011) suggested that the *IRAK4* gene haplotype, clade marked by 29429A (428Thr), modify the susceptibility to Gram-positive bacteria infection, by decreasing cellular response to TLR ligands.

It is probable that genetic variation alone does not create disease as such, but, instead confers susceptibility to its development, just as has been suggested for the host response in other fields of oral intervention \[[@CR19]\]. Thus, this predisposition to the disease development may require an interaction with an environmental factor to yield disease \[[@CR2]\].

According to Toby Hughes, genetic research means we can use it to determine the health status of individuals or even to influence how genes behave. So, there is the possibility to early monitor potential oral diseases in order to prevent or reduce their impact \[[@CR19], [@CR20]\].

This study analysed IRAK4 gene polymorphism \[marked by 29429A (428Thr)\] in a Portuguese Caucasian population. The clinical relevance of this study lies in trying to achieve a potential tool (a model) that may assist the clinician in the implementation of suitable dental treatment plans in complex cases, with probable involvement of the maxillary sinus.

The aim was to determine whether the haplotype clade marked by 29429A (428Thr) polymorphism had any influence on the development of changes in the maxillary sinus, particularly in the presence of etiological factors of dental origin.

Material and methods {#Sec2}
====================

*IRAK4* gene was selected as a candidate gene for this investigation based on its central function in innate and acquired immunity. The election of a specific *IRAK4* polymorphism was performed according to the host response against the oral flora.

Study subjects {#Sec3}
--------------

A retrospective study review was initially conducted to identify and characterize computed tomography (CT) imaging findings of a Portuguese Caucasian population. Institutional Review Board approval was obtained, and appropriate measures were taken to safeguard patient privacy.

The CT scans were performed according to the following indications: implant planning, study of impacted maxillary teeth, suspected lesion/cyst on the maxillary sinus, ankylosis of the anterior teeth, suspected foreign body in the maxillary sinus, endodontic lesions, oroantral fistula, orthodontic planning, local trauma and dental or bone fractures.

The criteria for patient selection were based on etiological factors of the maxillary sinusitis of odontogenic origin and the pathologic changes present in the maxillary sinus \[[@CR21]--[@CR23]\]. The CT's observed were from the period between 1993 and 2013. Two observers with over 20 years experience in the field of oral surgery identified the eventual changes present on CT.

In the analysed maxillary sinus, only the adjacent teeth to the maxillary sinus were evaluated \[[@CR22]--[@CR28]\] and the following signs were identified---opacity, presence of fluid, mucosal thickening, cortical bone loss \[[@CR21], [@CR29]\] and potential etiologic factors to develop sinusitis of odontogenic origin---teeth protruding into the maxillary sinus (maxillary sinus communication), dental caries, periodontal disease, apical periodontitis, endodontic treatment, iatrogenic signs, dental implants, cysts, foreign bodies, ectopic teeth, oroantral fistula and inclusion of teeth associated with maxillary sinus.

These completed a total of 504 patients, corresponding to 1008 analysed maxillary sinus.

From this base, 153 patients were randomly selected, according to the value of 13 % for the maxillary sinusitis prevalence, with 95 % CI and estimated error of 5.3 % to perform a genetic test.

According to the classification of Maillet et al. (2011), the patients were divided and included into four groups:Group IA:Presence of imagiological findings suggesting sinusitis of odontogenic origin---density of soft tissue mass or air-fluid within the sinus and presence of one of the following criteria: decayed tooth, tooth restoration faulty and extraction site with mucosal thickening. Forty-six (46) patients were identified in this group.Group IB:The sinus was considered healthy in the absence of mucosal thickening or uniform mucosal thickening less than 2 mm. Also, adjacent teeth should evidence signs of carious lesions, decayed tooth, exposed pulp, restoration, extraction and have imaging of apical periodontitis (presence of potential etiologic odontogenic factors). Thirty-four (34) patients were identified as having at least one of this potential etiologic odontogenic factors.Group IIA:Presence of soft tissue mass within the sinus---sinusitis of non-odontogenic origin, having fulfilled the following criteria: healthy teeth, coronal restoration and/or endodontic good quality, absence of periapical lesion, tooth extracted intact or healed alveoli and thickening of the mucosa not limited to any tooth. Thirty-five (35) patients were identified with this condition.Group IIB:Healthy patients---absence of mucosal thickening or uniform mucosal thickening less than 2 mm defective, having fulfilled the following criteria: healthy teeth, coronal restoration and/or endodontic good quality, absence of periapical lesion, tooth extracted intact or healed alveoli and thickening of the mucosa not limited to any tooth (absence of potential etiologic odontogenic factors). Thirty-eight (38) patients were considered in this group.

The genetic test was performed in the same appointment where the baseline demographics and medical data were recorded: familiar history of sinusitis, past maxillary sinus surgery, sinusitis or rhinitis diagnosed by an otolaryngologist, actual drug prescription, asthma or diabetes, smoking habit and presence of symptoms according to the Rosenfeld (2007) criteria---headache, nasal obstruction (congestion), ear pain, mucopurulent drainage, decreased sense of smell and dental pain. Intra-oral examination was carried out concerning facial pain on percussion or palpation, facial edema and erythema.

Inclusion criteria {#Sec4}
------------------

All adult Caucasian patients (\>18 years) who had at least one CT scan performed were included in this study. The patients with immune-compromised conditions, patients with CT without sufficient slices or poor quality image to analyze the maxillary sinus and patients with CT that did not allow analyzing the maxillary teeth were excluded.

Selection of polymorphism in the human *IRAK4* gene {#Sec5}
---------------------------------------------------

The *IRAK4* gene analysis was initially performed by sequencing all gene (Fig. [1](#Fig1){ref-type="fig"}). The latter was done by polymerase chain reaction (PCR) amplification and sequencing of the entire coding region, including the adjacent intronic regions of the *IRAK4* gene. In this first analysis, pathogenic mutations were not detected in the *IRAK4* gene. However, the variant c.1882G\>A (p.Ala428Thr) was found in heterozygosity (a single nucleotide polymorphism---SNP). This SNP was the same reported to be related with the host susceptibility for development of Gram-positive bacteria infection \[[@CR13]\].Fig. 1Sequencing image revealing a *IRAK4* gene polymorphism, translated by two peaks, indicated by the *arrow* and identified in a recruited patient study

After this SNP identification, the following samples were studied directly target to the c.1282G\>A (p.Ala428Thr) variant region (reference sequence: NM_001114182.2, being the A of the ATG start position 1). The primers selected to detect the SNP on the *IRAK4* gene are present in Table [1](#Tab1){ref-type="table"}. Furthermore, the D (down) was considered the forward, the U (up) the reverse and the 12/13 were together in just a fragment (because it was smaller and likely to be amplified with a single primer pair region).Table 1Primers used to detect the SNP on the *IRAK4* human gene \[Ref Seq: NM_016123\]PrimerSequenceIRAK4-3DTGTAAAACGACGGCCAGTAAAGGAAGCAAACCCAGAGGIRAK4-3UCAGGAAACAGCTATGACCGGGAACCACAGCAAAGGTGIRAK4-4DTGTAAAACGACGGCCAGTGCCTCTCGATCTTGGACTTCCIRAK4-4UCAGGAAACAGCTATGACCCACAGTGTCCTTTGTCTGTGCIRAK4-5DTGTAAAACGACGGCCAGTCTCTGATATAGGTGGCTCATGGIRAK4-5UCAGGAAACAGCTATGACCTGCCTGTGATTGCTGCACIRAK4-6DTGTAAAACGACGGCCAGTGTTCAGAGGGTAGGATCACCIRAK4-6UCAGGAAACAGCTATGACCGGTAGGGTCCATAGTGTTCAACIRAK4-7DTGTAAAACGACGGCCAGTATGGGCCTTGAGCAAATCACIRAK4-7UCAGGAAACAGCTATGACCCCTGTAGGTCCAGCTACTCGIRAK4-8DTGTAAAACGACGGCCAGTGGCTGAAAAGAGAAGTATTTGCIRAK4-8UCAGGAAACAGCTATGACCAATGGCAACCCAGTTGTTGIRAK4-9DTGTAAAACGACGGCCAGTATCATCTTCAGTTGTTGCCTAGIRAK4-9UCAGGAAACAGCTATGACCGAGCTTTCATGGAGTGATGGIRAK4-10DTGTAAAACGACGGCCAGTAAAGAGGACAGTTGCTTCTCIRAK4-10UCAGGAAACAGCTATGACCCCCACACCTATCTCTTGCTCIRAK4-11DTGTAAAACGACGGCCAGTATCTGTCTCCCAAAGTGCTGIRAK4-11UCAGGAAACAGCTATGACCCTGTCGTGTAATAGCCAATGGIRAK4-12DTGTAAAACGACGGCCAGTGAGCACATGTTATTACAAAGTAGIRAK4-13UCAGGAAACAGCTATGACCGTGTTTCCACCCTACATACAG

The genotypic analysis was performed in a blinded fashion, without clinical information. Patients' genotypes were determined by real-time PCR and the DNA sequencing resorted to the Sanger method.

Statistical analysis {#Sec6}
--------------------

Using the software IBM® SPSS® Statistics 22.0, the sample was characterized, an analytical study of association was conducted and data modelling was performed using the binary logistic regression, for dependent variable "diagnosis" corresponding to two categories, one for healthy individuals and the other for individuals with sinusitis of odontogenic origin. With this, the odds ratio due to the presence or absence of certain risk factor in this sample was evaluated.

After a univariate selection of variables, the construction of a model proceeded. In the construction of the logistic regression model, the forward stepwise technique was used to optimize variable selection, in order to select a set of variables that could contribute to the outcome and that this contribution revealed statistically significant. Therefore, in the previous univariate analysis, we took into account the *p* values obtained in the Wald statistic, and these variables enter as candidates to integrate the model.

The objective was to achieve a model that contained all variables that were important with regard to pre-established criteria of pE and pR values (*p* values of entry and removal of the variable in the model) chosen so that they become statistically and clinically significant. In other words, a variable could not present a *p* value \<0.05 but may be selected to include the model. Sometimes, a variable cannot have a significant effect individually, but in a particular set potentiate its effect on the outcome variable. That was performed taking into account the importance of the selected variable in the recent literature outlines and in the clinical setting.

Categorical variables were coded according to the technique referred by Hosmer and Lemeshow \[[@CR30], [@CR31]\].

Receiver operating characteristic (ROC) analysis is a useful tool for evaluating the performance of diagnostic tests and more generally for evaluating the accuracy of a statistical model (e.g. logistic regression, linear discriminant analysis) that classifies subjects into one of two categories, diseased or non-diseased \[[@CR19], [@CR31]\]. Using a graphical tool, ROC curve, and an accuracy measure such as the area under ROC curve, is in our days used for displaying the accuracy of a predictive model to estimate expected outcomes. So, to evaluate the accuracy of our model, we use ROC curve and its measure area under curve (AUC).

Results {#Sec7}
=======

The sample consisted of 153 individuals, of which 62 (40.5 %) were female and the remaining 91 (59.5 %) were male.

The prevalence of the polymorphism c.1282G\>A (p.Ala428Thr) in the variant region of the *IRAK4* gene in this sample was 26.8 %, with a confidence interval of 95 % \[20.1, 34.7 %\].

The Fisher exact test (*p* = 0.030 \< 0.05) showed statistically significant association between the presence of the *IRAK4* gene polymorphism and the mucosal thickening on CT imaging (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Illustration of the statistical association between the presence of *IRAK4* gene polymorphism (*positive genetic test*) and the presence of the mucosal thickening of maxillary sinus on computed tomography image

The Fisher exact test (*p* = 0.040 \< 0.05) revealed statistically significant association between the presence of the *IRAK4* gene polymorphism and the diagnosis of sinusitis of odontogenic origin (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Relation between the *IRAK4* gene polymorphism (*positive genetic test*) and maxillary sinusitis of odontogenic origin

Fisher's exact test was performed in order to determine a possible statistical relationship between the presence of the *IRAK4* gene polymorphism and the presence of diabetes or asthma. No significant associations were found.

Regarding the symptoms related to the diagnosis of maxillary sinusitis, there was no statistically significant association (*p* \> 0.05) between the *IRAK4* polymorphism and the symptoms individually (Table [2](#Tab2){ref-type="table"}).Table 2Results of the Fisher exact test for association between the *IRAK4* gene polymorphism and patient symptomsPatient symptoms*p* valueHeadache0.426Mucopurulent drainage0.342Nasal obstruction0.393Decreased sense of smell0.525Ear pain0.478Dental pain0.331

Also, a statistically significant association (*p* \> 0.05) between the *IRAK4* polymorphism and the different characteristics evaluated in the physical examination was not found (Table [3](#Tab3){ref-type="table"}).Table 3Results of the Fisher exact test for association between the *IRAK4* gene polymorphism and the evaluated parameters in the physical examinationPhysical examination*p* valuePalpation pain0.220Edema0.389Erythema0.283

As for the relation between the patient medication and the presence of evaluated genetic polymorphism (Table [4](#Tab4){ref-type="table"}), there was no statistically significant association (*p* \> 0.05).Table 4Results of Fisher exact test for association between the medication and the presence of *IRAK4* gene polymorphismMedication*p* valueAnticoagulants0.457Corticosteroids0.489Antihypertensives0.18Anti-depressants0.606Antibiotics0.604Anti-inflammatory0.17

The final sample to construct the prevision model was accomplished through the selection of two groups of the main sample (Groups IIB and IA). So, the latter consisted of 84 individuals, including 38 (45.2 %) (Group IIB) healthy and the remaining 46 were diagnosed with sinusitis of odontogenic origin (54.8 %) (Group IA).

The prevalence of the polymorphism c.1282G\>A (p.Ala428Thr) in the variant region of the *IRAK4* gene in this final sample was 32.1 %, with a confidence interval of 95 % \[22.6, 43.3 %\].

Thirty-four (40.5 %) of the individuals in this final sample were female, and the remaining 50 (59.5 %) were male. The Fisher exact test revealed that the distribution by sex according to the diagnosis was the same (*p* = 0.826) in the final sample. The age distribution in the final sample is shown in Table [5](#Tab5){ref-type="table"}.Table 5Age distribution according to diagnosis in the final sampleDiagnosticHealthyOdontogenic sinusitisTotalAge (years)Mean42.042.842.5Median41.543.542.0Standard deviation15.914.014.8Minimum18.018.018.0

The Student *t* test showed no statistically significant difference in the mean age of subjects in the two groups (*t* (82) = −0.238, *p* = 0.812) of the final sample.

In a first step of selecting variables to include in the model, the dependent variable was elected, which is the diagnosis (codes: 0 = healthy, 1 = sinusitis of odontogenic origin). Then, we proceeded to the univariate analysis by binary logistic regression. Thus, taking into account the *P* values obtained in the test of Wald statistics, the variables were considered as candidates to integrate the model indicated in Table [6](#Tab6){ref-type="table"}.Table 6Univariate logistic regressionVariables*B*S.E.WalddfSig.Exp (B)Gender0.1230.4460.07610.7821.131Family history of maxillary sinusitis1.9590.7976.04210.014^\*^7.091Motive of dental appointment0.9160.4534.08810.043^\*^2.500Maxillary sinusitis2.9821.0607.92110.005^\*^19.733Allergic rhinosinusitis2.3301.0754.70110.030^\*^10.278Diabetes−0.9510.8961.12710.2880.386Tobacco0.7300.5911.52210.2172.074Headache2.3560.7888.939^\*^10.003^\*^10.552Pressure3.1691.0578.981^\*^10.003^\*^23.786Ear pain21.28512,118.6360.00010.999^\#^1,753,944,115.096Mucopurulent drainage1.8780.6079.58410.002^\*^6.538Decreased sense of smell21.37510,742.0230.00010.998^\#^1,918,376,375.886Dental pain21.31411,602.7110.00010.999^\#^1,805,530,706.716Pain on percussion21.37510,742.0230.00010.998^\#^1,918,376,375.886Pain on palpation2.3301.0754.701^\*^10.030^\*^10.278Swelling/tumefaction21.28512,118.6360.00010.999^\#^1,753,944,115.096Erythema21.07923,205.4220.00010.999^\#^1,427,628,930.892Dentate behaviour on CT (computed tomography)−21.47623,205.4220.00010.999^\#^0.000Maxillary sinus communication2.6060.552^\*^22.24810.000^\*^13.538Dental implants21.15216,408.7110.00010.999^\#^1,534,701,100.709Dental decay21.05628,420.7210.00010.999^\#^1,395,182,818.826Periodontal disease21.10320,096.4850.00010.999^\#^1,461,620,095.913Periapical lesion21.5459220.9000.00010.998^\#^2,273,631,260.309Endodontic treatment21.5459220.9000.00010.998^\#^2,273,631,260.309Cysts21.17715,191.5150.00010.999^\#^1,574,052,410.983Oroantral fistula21.03440,192.9690.00011.000^\#^1,364,178,756.185Impacted teeth21.40610,377.7800.000^\#^10.998^\#^1,980,259,484.785Foreign bodies21.03440,192.9690.000^\#^11.000^\#^1,364,178,756.185Radiopacity22.0687338.1990.000^\#^10.998^\#^3,836,752,751.771Presence of air fluid21.15216,408.7110.000^\#^10.999^\#^1,534,701,100.709Mucosal thickening24.1476059.3180.000^\#^10.997^\#^30,694,022,014.172Cortical bone loss4.2401.06016.00710.000^\*^69.375Implant lesion21.07923,205.4220.00010.999^\#^1,427,628,930.892Genetic test0.9700.4983.79710.051^\*^2.639^\*^Indicates that there is a statistically significant association of this variable with the diagnosis groups^\#^Indicates instability due to the high value of the standard error, and was not considered for analysis

The variables marked with a number sign in Table [6](#Tab6){ref-type="table"} indicate instability due to the high value of the standard error, and were not considered for analysis. The values marked with an asterisk indicate that there is a statistically significant association of this variable with the diagnosis groups. So, every variable, with this result, was a good candidate to integrate the multivariate model. Therefore, from the univariate logistic regression results, the following candidate variables to enter the model---diagnosed sinusitis, nasal congestion, cortical bone loss, genetic test and maxillary sinus communication---were selected.

Using the forward conditional stepwise (with pE = 0.2 and pR = 0.25), we obtained a decision model in order to predict the result according to presence of a set of considered risk factors \[[@CR30]\]. The choice of pE and pR was made in accordance with Hosmer and Lemeshow that recommend, in models containing more variables, the use of a large *p* value to provide a more complete picture of possible models. The results obtained were summarized in Table [7](#Tab7){ref-type="table"}.Table 7Variables in the equation resulted from forward conditional stepwiseVariables*B*S.E.WaldDf*p* valueExp (B)Diagnosed sinusitis2.3411.2573.47110.06210.396Nasal congestion2.3671.2483.59610.05810.666Cortical bone loss3.6351.2029.14610.00237.898*IRAK4* gene polymorphism1.2390.7452.76510.0963.453Maxillary sinus communication1.0100.8331.47010.2252.745Constant−2.1210.56414.13910.0000.120*B* estimates for the slope coefficients of the univariate logistic regression model containing only this variable, *S.E.* the estimated standard error for the coefficient of the slope, *Df* degree of freedom, *Wald* Wald statistic, *Exp* (*B*) estimates for odds ratio

To evaluate the discriminatory power of the model to predict the result, we used the measured area under the ROC curve (AUC) \[[@CR32]\]. Figure [4](#Fig4){ref-type="fig"} represents the empirical ROC curve to the estimated probabilities to the decision model.Fig. 4Empirical ROC curve to the decision model

The area under the curve AUC = 0.911 means that the model could predict the outcome in 91.1 % of cases.

In multivariate logistic regression model, the probability estimated by the model, incorporating the *p* variables, can be written by the expression:$$\documentclass[12pt]{minimal}
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Thus, for the proposed model, an individual without sinusitis diagnosed, without complaints of feeling nasal congestion in the region of the maxillary sinuses, with cortical bone loss observed on CT, with a positive genetic test result and radiographic examination that reveals the roots of the teeth in communication with the maxillary sinus (maxillary sinus communication), it is estimated, by the model, a probability value of 0.977, to triggering an inflammatory response in the maxillary sinus.$$\documentclass[12pt]{minimal}
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Discussion {#Sec8}
==========

Currently, chronic diseases are a major cause of morbidity and mortality worldwide, and a large proportion of chronic diseases are preventable through risk factor management. Chronic disease prediction models have been developed to assist physicians/clinicians and individuals in clinical decision-making. A chronic disease prediction model assesses multiple risk factors together and estimates an absolute disease risk for the individual. In the selection of the variables to include a model, as suggested by Hosmer and Lemeshow, the level of 0.25 should be the chosen in this operation. These authors have demonstrated that using a traditional level (0.05) often fails to identify variables known to be "scientifically" relevant. As an example of this, we highlight the decision to include the variable genetic test on the construction of the model in our study. Moreover, we emphasize the principles of these authors in modelling---"The analyst, not the computer, is ultimately responsible for the review and evaluation of the model". In fact, accurate prediction of an individual's future risk for a certain disease could enable the comparison of benefits and risks of treatment, the costs of alternative prevention strategies and selection of the most efficient strategy for the individual. Although studies are subject to methodological difficulties/deficiencies, associations of chronic maxillary sinusitis (CRS) and polymorphisms in more than 30 genes have been published \[[@CR2]\]. While the individual risk conferred by these single nucleotide polymorphisms remains modest, taken as a group, they suggest an important implication of pathways of innate immune recognition and in regulation of downstream signalling in the development of maxillary sinusitis.

Taken individually, no single gene has emerged as uniquely causative of CRS. Although certain studies have reported high risk ratios, enthusiasm for these must be tempered by the small group size involved and the authors' reporting of a genotype-specific effect, rather than the allelic one commonly used. Second, very few of the SNPs identified have been in regions capable of altering amino acid sequences and secreted proteins. Nevertheless, a potentially interesting pattern does emerge. When the identified SNPs are modelled using ingenuity pathway analysis software, a gene-centric network around the *TNF*, *IL1A* and *NF*-*κB* genes becomes evident, suggesting a central role of this network in the pathology \[[@CR2]\]. In 2006, Anand et al. had already reported that there is overexpression of the major genes of the inflammatory pathway (*IL*-*6*, *IL*-*12A*, *IL*-*13* and *TNF*-*α*) in patients with CRS compared with the healthy population. Defining gene expression profiles may help elucidate new key factors in the pathogenesis of CRS and perhaps aid in the development of new therapeutic modalities \[[@CR33]\].

This provision may become especially important in implant procedures, usually placed in regions affected by tooth loss, periodontal disease, trauma and oral disease \[[@CR34], [@CR35]\].

As an example, the decision to extract a tooth with deficient endodontic treatment, affected with a periapical lesion, or to maintain it, may be evaluated with additional information about the prediction of the inflammatory response of the patient.

In extreme cases, after long-term edentulism, only a thin bone lamella separates the maxillary sinus from the oral cavity. In these cases, the placement of dental implants or procedures of maxillary sinus elevation for rehabilitation may become a challenging situation for the oral surgeon \[[@CR1]\].

Several techniques are used to overcome this obstacle, such as bicortical anchorage of dental implants, short implants and sinus floor elevation \[[@CR9]\]. If the implant penetrates more than 4 mm, the mucosa of the sinus floor does not spontaneously cover the implant. Then, the implant may act as a foreign body and turns into an inflammatory focus of the maxillary sinus \[[@CR26]\].

In a study performed with a population of 206 patients with severe chronic rhinosinusitis, three SNPs in the *IRAK4* gene were detected---rs1461567, rs4251513 and rs4251559---and associated with the increase of the total IgE serum levels (*p* \< 0.004). These results demonstrate a clear association between the *IRAK4* gene polymorphisms and IgE serum levels in patients with CRS and asthma \[[@CR36]\]. Therefore, *IRAK4* may play an important role in IgE levels' regulation in patients with inflammatory diseases of the airways. However, in our investigation, we did not find association between the *IRAK4* gene studied polymorphism and the presence of asthma. Perhaps this occurred because we did not study any of those three polymorphisms referred in the Tewfik study.

Literature studies correlating polymorphisms in the *IRAK4* gene with chronic maxillary sinusitis or even with maxillary sinusitis of odontogenic origin are scarce \[[@CR2], [@CR14]\]. However, the genome role importance in this disease has been increasingly evident and some studies even point to a relationship, as is the case of Zhang's (2011) study. The latter reported that the haplotype analysis GCCTGCGA was significantly associated with allergic rhinitis \[[@CR14]\].

Another study proposed a genetic predisposition to chronic sinusitis in the Japanese population, concluding that there was an association between *TNF*-*β* gene polymorphism and chronic sinusitis \[[@CR37]\].

The work performed by Sutherland and co-workers was the first report of an association of *IRAK4* gene polymorphisms with the prevalence and type of bacterial cultures in a cohort of critically ill patients, supported by mechanistic evidence of decreased cellular immune response to TLR ligands. Their finding that the *IRAK4* C/T/A clade was associated with decreased lymphoblastoid cell immune response to CpG dinucleotide (CpG---shorthand for "---C---phosphate---G---", cytosine and guanine are separated by only one phosphate) and with a trend to decreased immune response to LPS in IDFs transfected with the *IRAK4* expression plasmid carrying the 29429A allele suggests that the replacement of Ala428 with a threonine decreases the cellular response to TLR ligands, perhaps impairing the host's ability to clear an infection \[[@CR13]\]. Before that, Picard et al. proposed that*IRAK4* deficiencies predispose patients to recurrent life-threatening bacterial diseases, such as invasive pneumococcal disease, in infancy and early childhood, with weak signs of inflammation. This deficiency was associated with the innate immune response with time; hence, it is no longer so recurrent and fatal \[[@CR38]\].

These results, together with the knowledge that the oral flora responsible for odontogenic infections is the same implicated in odontogenic maxillary sinusitis (that is, mixed aerobic and anaerobic flora), lead one to think about the high risk that maxillary sinus is exposed to, after insult with a bacteria-laden displaced tooth root \[[@CR10]\]. Add to this, genetic susceptibility to developing infections by Gram-positive bacteria, in the presence of that specific gene polymorphism. So, the whole scene increases the likelihood of developing maxillary sinus pathology, with exacerbated symptoms and characteristics. Perhaps, this *IRAK4* gene polymorphism may amplify the response of the innate immunity to Gram-positive bacteria, thus increasing the cytokines production and leading to a more severe inflammatory state of the nasal/sinus mucosa. Hence, our study may be give rise to an initial tool (decision model), to be improved in order to help the diagnosis and the therapeutic decisions in such or similar cases.

Demonstration of a genetic association does not prove causality, which must be established by subsequent experiments showing the altered function of the gene and mechanistic impact in the disease.

Besides this, we conclude that the constructed model could be an initial primitive clinical tool. We are conscientious that chronic diseases are the result of the interaction of several factors. Most of them are even very distant from our assessment. However, if the general dentists and oral surgeons could have improved models, based on the primitive one we presented, probably it could assist in the diagnosis and treatment decision concerning procedures involving maxillary sinus. We emphasize that this primitive model obtained good results by the ROC curve analysis, but this does not mean that they are valid in any population. Thus, we consider that more studies are needed, with more risk factors, with other genes, in other populations, in order to construct more complete decision models, with better representativeness. The present work is only a primitive starting point.
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